Apelin在多囊卵巢综合征中的研究进展

doi:10.3969/j.issn.1004-583X.2023.03.017

摘要/Abstract

摘要：

多囊卵巢综合征(polycystic ovary syndrome,PCOS)是一种以高雄激素血症、排卵功能障碍、中心性肥胖和胰岛素抵抗为特征的妇科内分泌疾病。PCOS的发病机制复杂,临床表现具有高度异质性,目前以生活方式干预和药物治疗为主,但尚无特异、有效的预防和治疗药物。Apelin是一种与肥胖和胰岛素抵抗相关的新型脂肪因子,可能在PCOS的发生发展中起重要作用,是研究PCOS治疗药物的新靶点。本文主要就Apelin在PCOS中的研究进展进行综述,以期为PCOS发病机制的探讨及治疗药物的研发提供参考依据。

关键词: 多囊卵巢综合征, 爱帕琳肽, 胰岛素抵抗, 肥胖症, 代谢

中图分类号:

R711.75

江黎晨, 章秋, 胡红琳. Apelin在多囊卵巢综合征中的研究进展[J]. 临床荟萃, 2023, 38(3): 285-288.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2023.03.017

https://huicui.hebmu.edu.cn/CN/Y2023/V38/I3/285

参考文献 32

[1]	钱易, 马翔. 多囊卵巢综合征诊断标准解读[J]. 中国实用妇科与产科杂志, 2019, 35(3):264-267.
[2]	Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor[J]. Biochem Biophys Res Commun, 1998, 251(2):471-476. doi: 10.1006/bbrc.1998.9489 URL
[3]	Ranjbar Kohan N, Tabandeh MR, Nazifi S, et al. L-carnitine improves metabolic disorders and regulates Apelin and Apelin receptor genes expression in adipose tissue in diabetic rats[J]. Physiol Rep, 2020, 8(23):e14641.
[4]	Liu J, Liu M, Chen L. Novel pathogenesis: Regulation of apoptosis by Apelin/APJ system[J]. Acta Biochim Biophys Sin (Shanghai), 2017, 49(6):471-478. doi: 10.1093/abbs/gmx035 URL
[5]	Castan-Laurell I, Masri B, Valet P. The Apelin/APJ system as a therapeutic target in metabolic diseases[J]. Expert Opin Ther Targets, 2019, 23(3):215-225. doi: 10.1080/14728222.2019.1561871 URL
[6]	Sörhede Winzell M, Magnusson C, Ahrén B. The APJ receptor is expressed in pancreatic islets and its ligand, Apelin, inhibits insulin secretion in mice[J]. Regul Pept, 2005, 131(1-3):12-17. doi: 10.1016/j.regpep.2005.05.004 URL
[7]	Palmer ES, Irwin N, O'Harte FP. Potential therapeutic role for Apelin and related peptides in diabetes: An update[J]. Clin Med Insights Endocrinol Diabetes, 2022, 15:11795514221074679.
[8]	Marousez L, Hanssens S, Butruille L, et al. Breast milk apelin level increases with maternal obesity and high-fat feeding during lactation[J]. Int J Obes (Lond), 2021, 45(5):1052-1060. doi: 10.1038/s41366-021-00772-y
[9]	Yin C, Zhang H, Zhang M, et al. Adropin and Apelin-12 efficiently predict metabolic syndrome in obese children[J]. Pediatr Diabetes, 2020, 21(7):1132-1139. doi: 10.1111/pedi.v21.7 URL
[10]	Gourgue F, Mignion L, Van Hul M, et al. Obesity and triple-negative-breast-cancer: Is Apelin a new key target?[J]. J Cell Mol Med, 2020, 24(17):10233-10244. doi: 10.1111/jcmm.v24.17 URL
[11]	Bertrand C, Pradère JP, Geoffre N, et al. Chronic Apelin treatment improves hepatic lipid metabolism in obese and insulin-resistant mice by an indirect mechanism[J]. Endocrine, 2018, 60(1):112-121. doi: 10.1007/s12020-018-1536-1 pmid: 29392617
[12]	Yasir M, Senthilkumar GP, Jayashree K, et al. Association of serum omentin-1, Apelin and chemerin concentrations with the presence and severity of diabetic retinopathy in type 2 diabetes mellitus patients[J]. Arch Physiol Biochem, 2022, 128(2):313-320. doi: 10.1080/13813455.2019.1680698 URL
[13]	Griffiths PR, Lolait SJ, Paton JFR, et al. Circumventricular organ Apelin receptor knockdown decreases blood pressure and sympathetic drive responses in the spontaneously hypertensive rat[J]. Front Physiol, 2021, 12:711041. doi: 10.3389/fphys.2021.711041 URL
[14]	Yuan Y, Wang W, Zhang Y, et al. Apelin-13 attenuates lipopolysaccharide-induced inflammatory responses and acute lung injury by regulating PFKFB3-driven glycolysis induced by NOX4-dependent ROS[J]. J Inflamm Res, 2022, 15:2121-2139. doi: 10.2147/JIR.S348850 pmid: 35386222
[15]	Gören K, Saˇgsöz N, Noyan V, et al. Plasma Apelin levels in patients with polycystic ovary syndrome[J]. J Turk Ger Gynecol Assoc, 2012, 13(1):27-31.
[16]	彭丽敏, 韩丽荣, 焦玉梅. 多囊卵巢综合征不孕患者肠道菌群与血清性激素及脂肪因子关系[J]. 中国计划生育学杂志, 2022, 30(7):1612-1616.
[17]	蔡玉, 刁海丹. 血清TGF-β1、Apelin、CYP19A1水平与PCOS内分泌异常间的关系分析[J]. 生殖医学杂志, 2022, 31(4):463-467.
[18]	Sun X, Wu X, Zhou Y, et al. Evaluation of Apelin and insulin resistance in patients with PCOS and therapeutic effect of drospirenone-ethinylestradiol plus metformin[J]. Med Sci Monit, 2015, 21:2547-2552. doi: 10.12659/MSM.894926 URL
[19]	张全. 多囊卵巢综合征不孕患者血清CTRP3、chemerin、Apelin 变化及临床意义[J]. 中国计划生育学杂志, 2020, 28(2):184-188.
[20]	Altinkaya SÖ, Nergiz S, Küçük M, et al. Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome[J]. Eur J Obstet Gynecol Reprod Biol, 2014, 176:168-172. doi: 10.1016/j.ejogrb.2014.02.022 pmid: 24642195
[21]	Kolan Ska-Dams E, Boinska J, Socha MW. Adipokine levels and carbohydrate metabolism in patients diagnosed de novo with polycystic ovary syndrome[J]. Qatar Med J, 2021, 2021(2):34. doi: 10.5339/qmj.2021.34 pmid: 34604014
[22]	Gao Y, Xin C, Fan H, et al. Circulating Apelin and chemerin levels in patients with polycystic ovary syndrome: A meta-analysis[J]. Front Endocrinol (Lausanne), 2023, 13:1076951. doi: 10.3389/fendo.2022.1076951 URL
[23]	褚冉, 梁毓. 多囊卵巢综合征患者血清脂肪因子Asprosin、Apelin-13表达及与胰岛素抵抗关系[J]. 中国计划生育学杂志, 2022, 30(4):846-850.
[24]	OŻegowska K, Bartkowiak-Wieczorek J, Bogacz A, et al. Relationship between adipocytokines and angiotensin converting enzyme gene insertion/deletion polymorphism in lean women with and without polycystic ovary syndrome[J]. Gynecol Endocrinol, 2020, 36(6):496-500. doi: 10.1080/09513590.2019.1695248 pmid: 31814467
[25]	杜静, 张二红, 廖月婵, 等. 多囊卵巢综合征患者血清Apelin水平与激素、代谢异常的关系[J]. 中国妇幼保健, 2018, 33(05):1048-1050.
[26]	Jena D, Choudhury AK, Mangaraj S, et al. Study of visceral and subcutaneous abdominal fat thickness and its correlation with cardiometabolic risk factors and hormonal parameters in polycystic ovary syndrome[J]. Indian J Endocrinol Metab, 2018, 22(3):321-327. doi: 10.4103/ijem.IJEM_646_17 pmid: 30090722
[27]	Lazúrová I, Lazúrová Z, Figurová J, et al. Relationship between steroid hormones and metabolic profile in women with polycystic ovary syndrome[J]. Physiol Res, 2019, 68(3):457-465. pmid: 30904012
[28]	Hallajzadeh J, Khoramdad M, Karamzad N, et al. Metabolic syndrome and its components among women with polycystic ovary syndrome: A systematic review and meta-analysis[J]. J Cardiovasc Thorac Res, 2018, 10(2):56-69. doi: 10.15171/jcvtr.2018.10 pmid: 30116503
[29]	Podgórska M, Pietraszek-Gremplewicz K, Olszańska J, et al. The role of Apelin and Apelin receptor expression in migration and invasiveness of colon cancer cells[J]. Anticancer Res, 2021, 41(1):151-161. doi: 10.21873/anticanres.14760 pmid: 33419808
[30]	Uribesalgo I, Hoffmann D, Zhang Y, et al. Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy[J]. EMBO Mol Med, 2019, 11(8):e9266. doi: 10.15252/emmm.201809266
[31]	Cekmez F, Cekmez Y, Pirgon O, et al. Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrome[J]. Eur Cytokine Netw, 2011, 22(1):32-37. doi: 10.1684/ecn.2011.0279 pmid: 21411410
[32]	刘淼, 付丹, 王丹, 等. 多囊卵巢综合征不孕患者血清CTRP3、趋化素及Apelin水平变化意义探讨[J]. 临床和实验医学杂志, 2021, 20(24):2634-2637.

Apelin在多囊卵巢综合征中的研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 32

相关文章 15

编辑推荐

Metrics

本文评价

[1]	吕莎莎, 宋金兰, 石健. m.3243A>G突变相关线粒体糖尿病1例并文献复习[J]. 临床荟萃, 2024, 39(2): 160-163.
[2]	金家辉, 杨阳, 秦铜, 何雨欣, 苏美华. 补充益生菌对2型糖尿病患者糖代谢改善的meta分析[J]. 临床荟萃, 2023, 38(7): 581-587.
[3]	杨小雄, 杨帆, 魏小果. 肠-微生物群-肝轴与代谢相关脂肪性肝病的研究进展[J]. 临床荟萃, 2023, 38(6): 559-563.
[4]	宗廷妮, 戴光荣, 赵晓宇, 李瑞风, 柴聪敏. 代谢相关脂肪性肝病靶向药物治疗进展[J]. 临床荟萃, 2023, 38(4): 373-376.
[5]	韩拓, 王丽霞, 王怡雯, 李盈, 巩红, 张春艳, 张岩, 李永勤, 王聪霞. 健康人群中膳食营养素摄入与血糖及胰岛素抵抗相关性分析[J]. 临床荟萃, 2023, 38(2): 126-131.
[6]	任玉梅, 章秋, 胡红琳. 多囊卵巢综合征患者血清S100A4水平变化及其对多囊卵巢综合征的影响[J]. 临床荟萃, 2023, 38(12): 1078-1085.
[7]	刘亚鑫, 郭岚, 王泽凯, 牛凯. 慢性肾脏病合并骨质疏松症治疗的研究进展[J]. 临床荟萃, 2023, 38(12): 1146-1149.
[8]	张上仕, 朱红艳, 李楠, 陈鹰熙. 冠心病合并2型糖尿病患者冠状动脉病变与胰岛素抵抗的相关性分析[J]. 临床荟萃, 2023, 38(1): 46-49.
[9]	赵丽岩, 康玮, 王庆周, 李博鹏, 曹亚薇, 李俊粉, 邵亮, 王康. 脂质蓄积指数、内脏脂肪指数对2型糖尿病患者一级亲属糖代谢的影响[J]. 临床荟萃, 2022, 37(9): 804-807.
[10]	贾卓雅, 陈晓依, 陈树春. 胰高糖素样肽-1受体激动剂改善肥胖致雄性生殖功能下降的作用机制[J]. 临床荟萃, 2022, 37(7): 658-662.
[11]	杨静静, 黄帅, 吴倩, 赵丽丽, 蒋影. 胰高血糖素样肽-1受体激动剂治疗肥胖的研究进展[J]. 临床荟萃, 2022, 37(5): 477-480.
[12]	张莉敏, 孙军. FIB-4在代谢相关脂肪性肝病合并结直肠腺瘤性息肉患者的预测价值[J]. 临床荟萃, 2022, 37(4): 334-338.
[13]	齐琪, 江黎晨, 孙蓉, 胡红琳, 章秋. 妊娠中晚期孕妇血清Gremlin1水平变化及其对妊娠期糖尿病的影响[J]. 临床荟萃, 2022, 37(3): 257-261.
[14]	张雪晴, 陈树春. 血尿酸与高密度脂蛋白胆固醇比值在糖脂代谢相关疾病中的研究进展[J]. 临床荟萃, 2022, 37(11): 1044-1047.
[15]	宋学梅, 曹猛, 项丽君, 王园, 张晓梅. 危重患者的血糖管理[J]. 临床荟萃, 2022, 37(1): 66-71.